Clover Health Investments, Inc. (NASDAQ:CLOV – Get Free Report ) shares rose 6.8% during trading on Friday. The stock traded as high as $1.13 and closed at $1.10. 1,680,023 shares were traded during trading, down 79% from the session’s average trading volume of 8,153,913 shares. The stock closed at $1.03 earlier.
Clover Health Investments shares rose 5.8%
The stock has a market capitalization of $541.12 million, a price-to-earnings ratio of -3.21 and a beta of 2.09. The company’s 50-day simple moving average is $0.86 and its 200-day simple moving average is $0.90.
Clover Health Investments (NASDAQ:CLOV – Get free report ) last announced its earnings results on Tuesday, May 7th. The company reported quarterly EPS of ($0.05), beating the consensus estimate of ($0.07) by $0.02. The company’s quarterly revenue was $346.92 million, beating the consensus estimate of $316.10 million. Clover Health Investments had a net margin of -8.63% and a return on equity of -48.07%. On average, equities analysts expect Clover Health Investments Inc. to post an EPS of -0.21 for the current quarter.
Hedge Fund Rates Clover Health Investment
Several hedge funds have recently bought and sold shares of CLOV. Jupiter Asset Management increased its holdings in Clover Health Investments by 18.1% in the first quarter. Jupiter Asset Management now owns 4,525,079 shares of the company’s stock, valued at $3,593,000, after acquiring an additional 692,878 shares during the period. Connor Clark & ​​Lan Investment Management increased its holdings in Clover Health Investments by 2.6% in the third quarter. Connor Clark & ​​Lan Investment Management now owns 813,695 shares of the company’s stock, valued at $879,000, after acquiring an additional 20,813 shares during the period. Swiss National Bank increased its holdings in Clover Health Investments by 1.6% in the third quarter. Swiss National Bank now holds 782,200 shares of the company’s stock valued at $845,000 after purchasing an additional 12,400 shares during the period. Citigroup increased its holdings in Clover Health Investments by 4,040.8% during the third quarter. Citigroup now holds 372,421 shares of the company’s stock valued at $402,000 after purchasing an additional 363,427 shares during the period. Finally, Bayesian Capital Management LP purchased a new position in Clover Health Investments during the first quarter valued at approximately $142,000. 19.77% of the stock is held by institutional investors and hedge funds.
About Clover Health Investments
(Get your free report)
Clover Health Investments, Corp. offers Medicare Advantage plans in the U.S. The company operates in two segments: insurance and non-insurance. It also offers Clover Assistant, a cloud-based software platform that helps doctors detect, identify, and manage chronic diseases early and access data-driven, personalized insights about the patients they treat.
Feature Articles
Receive daily Clover Health Investments news and ratings –Enter your email address below to receive a concise summary of the latest news and analyst ratings on Clover Health Investments and related companies every day with MarketBeat.com’s free email newsletter.
